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Summary
Introduction. Facial morphogenesis occurs from the fourth to the twelfth gestation week, when the cells from nerve crest migrate 
to the region of face, forming the primary palate. The cleft palate is an abnormality in embryogenesis period, which is characterized 
by the absence of fusion of palatal shelves. The incidence of cleft lip and palate is one in 700 live births. In recent years the effect 
of different genes and signaling molecules, including Runx2, Wnt3 and OPG have been studied in the development of cleft palate, 
because these substances are considered to be regulators of pathogenesis responsible for formation of bone and cartilage tissue 
and particularly the bone.
Aim of the Study. The aim of the work was to evaluate the expression of Runx2, Wnt3 and OPG in palate bone and nasal cartilage 
for children with cleft palate.
Material and methods. Eleven bone and cartilage samples were obtained from 21 children of the lip, soft and hard palate correction 
surgery. All the patients were diagnosed with clefts of the lip, alveolar process of maxilla, and palate. In the tissue sections using the 
immunohistochemistry method (IMH), were determined Runx2 (code: AB192256, 1: 250, Abcam GB, rabbit), Wnt3 (code: AB1992, 
1: 800, Abcam GB, rabbit), and OPG (code: A0611, 1: 100, The Orbit USA, rabbit) local expression. We used a semi-quantitative 
census method for quantifying the positive structures.
Results. Runx2 expression was observed in five patient bone tissue samples and six patient cartilage tissue samples. Of the Runx2 
positive bone tissue, in one case we observed occasional, in two cases- few, in one case- moderate to numerous and in one case 
numerous positive osteocytes while in tissue of cartilage in two cases we observed few, in one case- few to moderate, in two cases- 
moderate, and in one case numerous positive chondrocytes. A significant difference in Wnt3 expiation was observed between bone 
and cartilage tissues. Wnt3 expressing chondrocytes were observed in all samples, where in one case- occasional, in three cases-
few, in one case-moderate, and in six cases-numerous positive cartilage cells were observed. The expression of the gene in the bone 
was observed in nine cases, which contained mostly occasional or few positive structures, except in three cases where in one Wnt3 
was marked by few to moderate and in two cases numerous positive osteocytes. OPG expression was observed in all samples, but 
in the cartilage, the expression was more pronounced. In the cartilage in seven cases, there were numerous positive chondrocytes, 
in one case- few to moderate, in two cases moderate to numerous and in one case few to moderate number of chondrocytes. OPG 
showed variable expression. In four cases, we observed occasional to few, in one case few to moderate, in one case- moderate, in 
one case moderate to numerous and in four cases numerous positive bone cells.
Conclusion. Cartilage tissue expresses significantly more Runx2, Wnt3 genes and OPG proteins, indicating a greater compensatory 
tissue capacity. In the case of palate clefts, the high expression of Wnt3 and OPG and lower expression of Runx2 could indicate 
a significant tissue proliferation which predominates over mineralization and ossification processes.
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INTRODUCTION
The cleft palate is an abnormality in the embryogenesis 
period, characterized by a loss of fusion of palatal 
shelves (1). The lip and palate clefts are found in one 
in 700 live births worldwide (17). About 70% of all 
lip and palate clefts are nonsyndromic, while the 
remaining 30% are associated with other hereditary 
abnormalities. The largest number of nonsyndromic lip 
and palate cleft is found in North American Indian and 
Asian populations, where incidence ranges from one to 
500 in live birth children. The interaction of teratogenic 
factors and genes is important for the development of 
the lip and palate. In the case of clefts, the effects of 
different locuses have been shown in chromosomes 1, 
2, 3, 4, 6, 18, 19 and 21, but the main teratogenic factors 
are maternal stress, alcohol use, smoking and the effect 
of folic acid in pregnancy (16).
In recent years, attention has been paid to specific 
genes and proteins in the process of cleft development, 
which directly affects the morphological processes of 
tissues (21).
Runx2 belongs to the Runx gene family, which 
is responsible for encoding transcription factors, 
mainly by engaging in cell differentiation (4). There 
are three distinct Runx genes. Runx1 is involved in 
hematopoiesis, Runx2 in sceletogenesis, but the role 
of Runx3 has not been fully understood (18). Runx2 
primary importance is in osteoblast differentiation and 
cartilage hypertrophy in the primary palate, as well 
as Runx2 is associated with cell migration and bone 
vascularisation (3). The Runx2 gene in the bone mainly 
promotes mineralization and stimulates osteoblast 
proliferation (6). Researches have shown the effect 
of the osteoblast specific transcription factor Runx2 
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on the differentiation of mesenchymal stem cells to 
primary osteoblasts in cartilage tissue (22). Runx2 in 
immature chondrocytes promote cartilage hypertrophy 
(13). Runx2 are expressed mainly by hypertrophic 
perichondrocytes, which indicate the initial ossification 
process (8). Runx2 has also been shown to play a role 
in osteoarthritis, affecting mesenchymal cells. This gene 
promotes the activity of osteoblasts and chondrocytes, 
thereby promoting ossification processes (19).
Wnt3 is a determinant gene of signaling molecules 
that belongs to the Wnt gene family and regulates 
various morphogenetic processes, including cellular 
polarity detection, differentiation and migration 
(14). In the embryogenesis period, the role of Wnt3 
is in bone mass formation through mesenchymal cell 
proliferation, regeneration of stem cells, and stimulation 
of preosteoblastic replication. In this developmental 
period, Wnt3 is believed to be involved in inhibition 
of osteoblast and osteocyte apoptosis and stimulation 
of developing the osteoblasts. The Wnt3 gene affects 
mesenchyme, causing it to form into osteoblasts 
(9). The Wnt3 gene in in cartilage tissue inhibits its 
proliferation and triggers the process of differentiation 
of the chondrocyte, which later, through involvement 
of other genes, will contribute to the ossification 
process (7). Recent studies have shown the direct 
activating effect of the Wnt3 gene signaling molecules 
on the active component of T cell transcription factor 1 
(TCF1),which is a Runx2 gene promoter, thus activating 
the Runx2 gene in mesenchymal cells (5). In recent 
years, the Wnt3 gene is increasingly associated with lip 
and palate cleft, but the involvement of the gene in the 
pathogenesis mechanism is not completely clear (15).
Osteoprotegerin (OPG) is a protein belonging to the 
Tumor Necrosis Factor (TNF) gene family. Mostly, these 
proteins are synthesized by osteoblasts and play an 
important role in bone remodeling (11). OPG binds to 
the receptor activator of nucleic factor kappa B ligand 
(RANKL) to form the OPG / RANKL complex, prevents 
it from binding to the receptor activator of nuclear factor 
kappa B (RANK), which is present on the osteoclast cell 
surface, thereby inhibiting osteoclast differentiation and 
proliferation (20). OPG and RANKL play a primary role 
in bone metabolism process. Expression of OPG synthesis 
increases OPG / RANKL complex ratio, resulting in 
reduced bone remodeling (11). Tissue stress plays an 
important role in the inhibition of osteoclast and bone 
proliferation. Tissue stress is carried out through bone 
tissue metabolism, where OPG synthesis increases. 
In various studies, bone tissue stress is associated 
with tissue impairment, ultrasound, gravitation and 
mechanical damage. The increased OPG / RANKL ratio 
is associated with Paget's disease, benign and malignant 
bone tumors, metastatic processes, rheumatoid arthritis 
and postmenopausal osteoporosis (10). The effect 
of OPG on the development of palate clefts has been 
studied very little so far. OPG expression in palate bone 
tissues in children with lip and palate clefts has been 
demonstrated, suggesting osteoclast dysregulation in 
the morpho-pathogenetic process of the cleft (12). The 
WNT gene is believed to increase the level of OPG by 
reducing osteoclastogenesis and increasing the build-up 
of bone tissue in the cleft affected tissues (2).
AIM OF THE STUDY
The aim of the work was to evaluate the expression 
of Runx2, Wnt3 and OPG in palate bone and nasal 
cartilage for children with cleft palate.
MATERIAL AND METHODS
The material used in the study was obtained from lip, 
soft and hard palate correction surgeries in the Cleft 
Lip and Palate Centre of Institute of Stomatology of 
the Riga Stradiņš University from a period of time from 
2003 to 2009. The study included 11 bone tissue and 
11 cartilage tissue samples from 21 patients with clefts 
of the lip, alveolar process, hard and soft palate. The 
patient's age varied between seven and 21 years of age 
during the correction surgery.
The material obtained during the correction surgery 
was immediately fixated in transport test tubes with 
Stefanini (Zamboni) solution and delivered to RSU AAI 
Laboratory of Morphology for further tissue processing.
After tissue fixation, the material was rinsed for 24 hours 
in a solution of Tyrode. The increase concentration of 
alcohol solution was used for tissue dewatering. The 
tissue was put into xylene for 30 minutes for degreasing. 
For the hardening the tissue was applied to the paraffin 
for 1 hour and in the paraffin for 2 hours.
Tissue blocks were cut into sections of 3 micrometers 
with semi-automatic rotary microtom (Leica RM2245, 
Leica Biosystems Richmond Inc., United States). 
Sections were fixed on slides and dried in a thermostat, 
later re-dewaxed in xylene and dehydrated in various 
alcoholic solutions. The tissue sections were dyed with 
hematoxylin and eosin to obtain a general overview. 
The immunohistochemistry method was used for the 
expression of genes and proteins in the tissues.
In the tissue sections, using the immunohistochemistry 
method, Runx2 (code: AB192256, working dilution 1: 
250, Abcam, Great Britain, rabbit monoclonal), Wnt3 
(code: AB1992, working dilution 1: 800, Abcam, Great 
Britain, rabbit polyclonal), and OPG (code: A0611, 
working dilution 1: 100, The Orbit, United States, rabbit 
polyclonal) local expression was obtained.
The semi-quantitative census method was used for the 
quantification of immunological structures (Pilmane 
1997). The labels were as follows: (0) - no positive 
structure was detected in the visual field (0 / +) - 
occasional positive structures seen in the visual field, (+) - 
few positive structures seen in the visual field, (+ / ++) – 
few to moderate number of positive structures seen in 
the visual field, (++) – moderate number of positive 
structures seen in the visual field, (++ / +++) – moderate 
to numerous positive structures seen in the visual field, 
(+++) - numerous positive structures seen in the visual 
field, (+++ / ++++) - numerous to abundance of positive 
structures seen in the visual field, (++++) – abundance 
of positive structures seen in the visual field.
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RESULTS
The expression of Runx2, Wnt3, and OPG positive 
structures in the tissues was variable. Compared to 
bone tissue, the detection of genes and signal molecules 
was better observed in cartilage tissue, except in two 
cases where we observed moderate to numerous and 
numerous Runx2, Wnt3 and OPG positive cells in the 
bone tissue (see Table 1).
Runx2 expression was observed in five patient bone 
tissue and six cartilage tissue samples. From Runx2 
positive bone tissue samples, in one case, we observed 
occasional, in two cases- few, in one case- moderate to 
numerous and in one case- numerous positive osteocytes 
(see Figure 1). On the other hand, in cartilage tissue, 
in two cases we observed occasional, in one case- few 
to moderate, in two cases- moderate, and in one case, 
numerous positive chondrocytes (see Figure 2).
A significant difference in Wnt3 expression was 
observed between the bones and cartilage. Wnt3 
expressing chondrocytes were observed in all samples, 
in which one case we observed occasional, in three cases 
few, in one case- moderate and in six cases, numerous 
Wnt3 positive cartilage cells (see Figure 3 and Figure 6). 
The expression of the gene in the bone was observed in 
nine cases, which contained mostly occasional or few 
positive structures, except in three cases where Wnt3 
was marked by few to moderate and in two cases- 
numerous positive osteocytes (see Figure 4).
OPG expression was observed in all samples, but 
expression in cartilage was more pronounced. In the 
cartilage in seven cases, there were numerous positive 
chondrocytes observed (see Figure 5), in one case – 
moderate to numerous, in two cases - moderate, and 
in one - few to moderate amount of chondrocytes. In 
the bones OPG was expressed variably. In four cases, 
we observed occasional to few, in one case – few to 
moderate, in one case- moderate to numerous, and in 
four cases, numerous positive bone cells.
DISCUSSION
In the bone, the Runx2 gene mainly promotes bone 
mineralization and osteoblast proliferation, thereby 
promoting bone modulation (6). The expression of this 
gene in cartilage shows an initial ossification (13).  By 
promoting ossification, the development of the bone 
is also enhanced in the cleft palate. In our study, the 
expression of the Runx2 gene in bone was practically 
not observed, but the expression of gene in cartilage 
was weak, indicating a reduced mineralization of the 
tissues, but more active cartilage proliferation.
In our study, the presence of Wnt3 gene was observed in 
cartilage tissue, which indicates initial ossification in the 
cartilage. It has been shown that the Wnt3 gene mainly 
inhibits cartilage proliferation and induces chondrocyte 
differentiation (7), promoting bone development. 
Compared to the cartilage, the expression of Wnt3 in 
the bone was convincingly weaker, suggesting a weaker 
osteoblast involvement, thus weak bone mineralization. 
Studies have shown that the presence of the Wnt3 gene 
in osteoblast shows its proliferation (9).
OPG binds to the RANKL ligand to form the OPG / 
RANKL complex, in a result RANKL cannot bind to the 
RANK receptor located on the surface of the osteoclast 
cell, thereby inhibiting osteoclast differentiation and 
proliferation (20). The presence of OPG in the tissues 
indicates a reduction of cartilage and bone tissue 
reabsorption, promoting tissue development. In our 
study, we observed a significant presence of OPG, both 
in bone and in cartilage, indicative of compensatory 
tissue proliferation. We believe this is an essential early 
compensating mechanism in the case of cleft palate.
Since the expression of Wnt3 and OPG in cartilage 
tissue was more pronounced in comparison to bone 
tissue, except in two cases where in the bone all of these 
genes and proteins were observed in moderate and 
numerous osteocytes, therefore, we assume that tissue 
proliferation plays a more important role in the cleft 
palate, but tissue mineralization has less importance.
CONCLUSIONS
Increased cartilage tissue secretion of Runx2, Wnt3 genes 
and OPG proteins, proves probably the compensatory 
tissue capacity in case of clefts.
In the case of cleft lip and palate, the high expression of 
Wnt3 and OPG and less expressed Runx2 could indicate 
significant tissue proliferation predominance over 
mineralization and ossification processes.
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Table 1. The relative amount of Runx2, Wnt3 and OPG positive structures in the tissues obtained during the 
correction of lip, hard and soft palate
Nr. Numeral Runx2 Wnt3 OPG
Cartilage Bone Cartilage Bone Cartilage Bone
1 48/1 0 0/+ +++
2 58/1 0 0 +
3 72/2 0 +/0 +
4 76/5 0/+ + 0/+
5 85 B/1 0 + +/++
6 120 0 0 +
7 122/6 0 + ++
8 208/2 + +/++ +++
9 239/2 +++ +++ +++
10 175/1 ++/+++ +++ ++/+++
11 15/3 0/+ 0/+ +++
12 15/5 0/+ + +++
13 22 +/++ +++ +++
14 28 ++ + ++/+++
15 47/1 0 + +++
16 47/2 0 + ++ + ++ +++
17 58/2 0 +++ ++
18 58/4 ++ +++ +++
19 61/1 0 +++ +++
20 64/1 0 +++ +/++
21 110/7 +++ +++ +++
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Fig. 1. Moderate to many Runx2 positive 
osteocytes in bone tissue for the patient with cleft 
lip and palate. Runx2 IMH x250
Fig. 3. Moderate to numerous Wbt3 positive 
chondrocytes in cartilage tissue for patient with 
cleft lip and palate. Wnt3 IMH, x250
Fig. 5. Numerous positive chondrocytes in cartilage 
tissue for patient with cleft lip and palate. OPG 
IMH, x200
Fig. 2. Numerous Runx2 expressing chondrocytes 
in cartilage tissue for the patient with cleft lip and 
palate. Runx2 IMH x400.
Fig. 4. Moderate to numerous Wnt3 positive 
osteocytes in bone tissue for patient with cleft lip 
and palate. Wnt3 IMH, x250
Fig. 6. Moderate to numerous Wnt3 positive 
osteocytes in bone tissue for patient with cleft lip 
and palate. Wnt3 IMH, x250
